Introduction

Bacteroides caccae is a Gram-negative bacterium and a prominent member of the Bacteroidaceae family within the human gut ecosystem. As a versatile symbiont, it plays a significant role in breaking down complex dietary components and modulating the host's immune environment. Understanding its abundance and functional potential is crucial, as this microbe is associated with a wide spectrum of health outcomes, ranging from enhancing the efficacy of cancer immunotherapies to serving as a marker for certain metabolic imbalances.

Location of Microbe

Primary Habitat

Bacteroides caccae primarily resides in the large intestine, where it thrives as part of the dense microbial community. It is specifically adapted to the anaerobic environment of the gut lumen, allowing it to ferment dietary residues and interact with the intestinal mucosa.

Behavior During Dysbiosis

Microbial Shifts

During states of dysbiosis, the abundance of Bacteroides caccae can shift significantly depending on the condition. In some metabolic imbalances, such as dyslipidemia, it may increase in abundance and become associated with inflammatory processes. Conversely, its depletion is observed in other conditions, such as liver fibrosis or pregestational type 2 diabetes mellitus, where the loss of this species may reflect a broader decline in microbial diversity and the breakdown of beneficial microbial networks.

Environmental Sensitivity

B. caccae is also sensitive to pharmacological interventions. Certain oral medications, including non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, can inhibit its growth and trigger prophage induction, leading to the lysis of the bacterial cell and subsequent alterations in the gut virome.

Disease Associations

Metabolic and Organ Health

In the context of dyslipidemia, an increased abundance of Bacteroides caccae is associated with abnormal blood lipid levels and inflammation. In contrast, a depletion of this species is associated with liver fibrosis in high-risk populations. Furthermore, in pregnant women with pregestational type 2 diabetes mellitus (PGDM), B. caccae is significantly overrepresented in healthy controls, suggesting that its reduction is associated with hyperglycemic traits and weaker microbial interactions during pregnancy.

Oncology and Immune Response

The relationship between B. caccae and cancer is complex. It has been identified as a strong biomarker for immunotherapy efficacy; patients responding well to immune checkpoint inhibitors in both melanoma and non-small-cell lung cancer (NSCLC) often show an enrichment of this species. However, B. caccae is also identified as a contributing species associated with gastric cancer, particularly in late-stage progression, and its enrichment has been associated with an increased risk of NSCLC.

Renal and Other Associations

In patients with chronic kidney disease (CKD) undergoing hemodialysis, there is a significant abundance of B. caccae. These patients often exhibit an enrichment of pathways related to the production of uremic toxins, which may complicate the clinical condition of the host. Additionally, changes in this species have been observed in individuals with HIV infection and those in the MSM (men who have sex with men) population, where it is linked to broader shifts in the gut microbiome composition.

Foods Supporting Healthy Balance

Maintaining a healthy balance of Bacteroides caccae involves managing the intake of dietary proteins and complex carbohydrates. B. caccae is highly equipped for proteolysis, producing a vast array of proteases to break down dietary proteins. While moderate protein intake supports its growth, excessive amounts of animal proteins—typical of some Western diets—can lead to increased proteolytic activity in the colon, which is sometimes associated with inflammatory bowel diseases.

To support a balanced ecosystem, incorporating a variety of fucosylated glycans is beneficial. B. caccae possesses α-l-fucosidases that allow it to assimilate fucose from human milk oligosaccharides (HMOs) and mucosal glycans, which are essential for shaping the microbiota, especially in early life. Balancing these with a diverse range of fibers helps prevent the dysbiosis associated with the overgrowth of opportunistic species while maintaining the functional potential of the gut barrier.

Actionable Insights

• Monitor Protein Intake: Since B. caccae is a primary protein-degrader, balancing protein sources (mixing animal and plant proteins) may help prevent excessive proteolytic fermentation in the colon.
• Prioritize Diverse Fibers: Consuming a wide array of prebiotic fibers supports the overall microbial diversity, helping to maintain B. caccae at levels that support immune efficacy without triggering inflammation.
• Cautious Medication Use: Be aware that common medications like NSAIDs (e.g., ibuprofen) can directly impact B. caccae abundance and induce prophages, potentially altering the gut ecosystem.
• Support for Early Life: For infants, the presence of fucosylated glycans in breast milk is critical for the healthy establishment of species like B. caccae.

Conclusion

Bacteroides caccae serves as a multifaceted component of the human gut ecosystem, acting as a vital metabolic engine for protein and glycan degradation. Its role is highly context-dependent; while its presence is strongly associated with positive responses to cancer immunotherapies, its overabundance or depletion is linked to various metabolic and inflammatory conditions, including dyslipidemia and type 2 diabetes. Ultimately, the impact of B. caccae on host health depends on the specific strain and the wider microbial community structure. Maintaining a diverse, fiber-rich diet is the best approach to ensuring this microbe supports systemic health and immune function without contributing to dysbiosis.